|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/introduction-to-nutraceuticals/
课程评论：没有评论
课程名称：营养保健品入门（初学者水平） 课程概述：“营养保健品”是一种可能被视为食品或食品组成部分的物质，提供医疗或健康益处，包括疾病的预防和治疗。营养保健品的产品种类繁多，包括单一营养素、膳食补充剂、基因工程"定制"食品、草本产品以及加工食品（如谷物、汤、饮料）等。根据印度2006年的《食品安全与标准法》第22条，营养保健品已被定义。从安全性角度来看，即使未获得像药品这样的权威机构批准，营养保健品仍被视为可信产品。许多营养保健品经过临床研究，结果支持其有效性及总体安全性。营养保健品是具有生物活性的植物化学物质，能够为健康带来好处。这些产品可以作为膳食补充剂和/或功能性食品提供给消费者。营养保健品在促进人类健康和延年益寿方面可能发挥重要作用。绝大多数公众在消费这些产品时通常不需要医疗处方和/或监督。因此，消费者信心对膳食补充剂行业的增长和生存有着直接且巨大的影响。近年来，由于某些质量问题和/或健康不良反应，行业增长受到了打击。这种情况愈发显示出对加强监管和在各个生产阶段监控产品以确保质量和完整性的迫切需求。为此，已加强了安全保障的开发和实施，比如良好生产规范、TruLabel、质量认证、产品评审以及质量验证。同时，某些领域如原材料一致性与可追溯性、良好农业实践及防范生物恐怖主义，仍可能对营养保健品市场产生负面影响。近期在植物材料的识别和标准化、由人类细胞系筛选及基因表达导向分级等方面的改进，有望加速新营养保健品和药物的开发。
"Nutraceutical" is a substance that may be considered a food or part of food that provides medical or health benefits, encompassing prevention and treatment of disease. Products as diverse as isolated nutrients, dietary supplements, and diets to genetically engineered "designer" foods, herbal products, and processed foods (cereals, soups, beverages) may be included under the umbrella of nutraceuticals. In India, nutraceuticals have been defined under Clause 22 of the Food Safety and Standards Act (FSSA), 2006. From a safety point of view, nutraceuticals are trusted products even if they are not approved by authorities like pharmaceuticals. With a lot of nutraceuticals, clinical studies have been carried out and results originating from these trials support their effectiveness as well as their general safety. Nutraceuticals are biologically active phytochemicals that possess health benefits. These may be delivered to the consumer as a dietary supplement and/or as a functional food. These products are likely to play a vital role in human health and longevity. The consumption of these products by the vast majority of the public is usually without a medical prescription and/or supervision. The impact of consumer confidence in the growth and survival of the dietary supplement industry is, therefore, direct and enormous. In recent years, the industry has suffered a setback in its growth, due to certain instances of quality failures and/or adverse health effects. This situation has created an urgency for increased regulatory oversight and for monitoring the products at various stages of manufacturing for quality and integrity. Development and implementation of safeguards - such as good manufacturing practice(s), TruLabel, quality certification, product reviews, and quality demonstration/verification - have since been intensified. Certain areas, such as raw material uniformity and traceability, good agricultural practices, and protection from bioterrorism, may still have the potential to impact the nutraceutical markets negatively. Recent improvements in the identification and standardization of botanical materials, coupled with screening by human cell line and gene expression-directed fractionation, are expected to expedite the development of new nutraceuticals and drugs.
